Abstract
The prognosis of patients with chronic respiratory tract infections, especially diffuse panbronchiolitis, is remarkably improved by long-term administration of low-dose macrolides. However, in some cases, patients are refractory to macrolide treatment and show a low or no response; therefore, new treatment strategies are required. Here we present a patient refractory to either single low-dose clarithromycin or azithromycin but responded remarkably to the combination usage of both macrolides.
Original language | English |
---|---|
Pages (from-to) | 1383-1386 |
Number of pages | 4 |
Journal | Internal Medicine |
Volume | 51 |
Issue number | 11 |
DOIs | |
State | Published - 2012 |
Keywords
- Azithromycin
- Chronic respiratory tract infection
- Clarithromycin
- Pseudomonas aeruginosa
ASJC Scopus subject areas
- Internal Medicine